Literature DB >> 24399671

Net time-dependent ROC curves: a solution for evaluating the accuracy of a marker to predict disease-related mortality.

Marine Lorent1, Magali Giral, Yohann Foucher.   

Abstract

Developing prognostic markers of mortality for patients with chronic disease is important for identifying subjects at high risk of death and optimizing medical management. The usual approach in this regard is the use of time-dependent ROC curves, which are well adapted for censored data. Nevertheless, an important part of the mortality may not be due to the chronic disease, and it is often impossible to individually determine whether or not the deaths are related to the disease itself. In survival regression, one solution is to distinguish between the expected mortality of one general population (from life tables) and the excess mortality related to the disease, by using an additive relative survival model. In this paper, we propose a new estimator of time-dependent ROC curves, which includes this concept of net survival, in order to evaluate the capacity of a marker to predict disease-specific mortality. We performed simulations in order to validate this estimator. We also illustrate this method using two different applications: (i) predicting mortality related to primary biliary cirrhosis of the liver and (ii) predicting mortality related to kidney transplantation in end-stage renal disease patients. For each application, we evaluated a scoring system already established. The results demonstrate the utility of the proposed estimator of net time-dependent ROC curves.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  disease-specific mortality; primary biliary cirrhosis of liver; prognostic; renal transplantation; time-dependent ROC curves

Mesh:

Substances:

Year:  2014        PMID: 24399671     DOI: 10.1002/sim.6079

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors.

Authors:  Si Yang; Ying Wu; Yujiao Deng; Linghui Zhou; Pengtao Yang; Yi Zheng; Dai Zhang; Zhen Zhai; Na Li; Qian Hao; Dingli Song; Huafeng Kang; Zhijun Dai
Journal:  Oncoimmunology       Date:  2019-10-03       Impact factor: 8.110

2.  Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy.

Authors:  Zheng Wang; Jingru Song; Nisma Lena Bahaji Azami; Mingyu Sun
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

3.  Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment.

Authors:  Fangfang Xu; Jiacheng Shen; Shaohua Xu
Journal:  Front Genet       Date:  2021-05-24       Impact factor: 4.599

4.  Integrated analysis of single-cell RNA-seq dataset and bulk RNA-seq dataset constructs a prognostic model for predicting survival in human glioblastoma.

Authors:  Wenwen Lai; Defu Li; Jie Kuang; Libin Deng; Quqin Lu
Journal:  Brain Behav       Date:  2022-04-16       Impact factor: 3.405

5.  Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area.

Authors:  Mu-Xing Li; Hong Zhao; Xin-Yu Bi; Zhi-Yu Li; Xue-Song Yao; Huai Li; Zhen Huang; Yue Han; Jian-Guo Zhou; Jian-Jun Zhao; Ye-Fan Zhang; Dong-Bin Zhao; Jian-Qiang Cai
Journal:  Oncotarget       Date:  2016-12-27

6.  Severely malnourished children with a low weight-for-height have a higher mortality than those with a low mid-upper-arm-circumference: I. Empirical data demonstrates Simpson's paradox.

Authors:  Emmanuel Grellety; Michael H Golden
Journal:  Nutr J       Date:  2018-09-15       Impact factor: 3.271

7.  HPV-related methylation-based reclassification and risk stratification of cervical cancer.

Authors:  Si Yang; Ying Wu; Shuqian Wang; Peng Xu; Yujiao Deng; Meng Wang; Kang Liu; Tian Tian; Yuyao Zhu; Na Li; Linghui Zhou; Zhijun Dai; Huafeng Kang
Journal:  Mol Oncol       Date:  2020-06-02       Impact factor: 6.603

8.  Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.

Authors:  Rui-Lian Chen; Jing-Xu Zhou; Yang Cao; Ling-Ling Sun; Shan Su; Xiao-Jie Deng; Jie-Tao Lin; Zhi-Wei Xiao; Zhuang-Zhong Chen; Si-Yu Wang; Li-Zhu Lin
Journal:  Front Immunol       Date:  2020-09-15       Impact factor: 7.561

9.  Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.

Authors:  Yanan Peng; Chang Liu; Mengting Li; Wenjie Li; Mengna Zhang; Xiang Jiang; Ying Chang; Lan Liu; Fan Wang; Qiu Zhao
Journal:  Cancer Cell Int       Date:  2021-02-10       Impact factor: 5.722

10.  A 17-gene expression-based prognostic signature associated with the prognosis of patients with breast cancer: A STROBE-compliant study.

Authors:  Jin-Xian Qian; Min Yu; Zhe Sun; Ai-Mei Jiang; Bo Long
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.